Results for tag: "Dopamine Antagonist"

The Dopamine Antagonist market within the context of Gastrointestinal Drugs is a subset of the pharmaceutical industry that focuses on the development and production of drugs that target the dopamine receptors in the gastrointestinal tract. These drugs are used to treat a variety of gastrointestinal disorders, including nausea, vomiting, and irritable bowel syndrome. Dopamine antagonists are also used to treat certain types of depression, anxiety, and schizophrenia. The dopamine antagonist market is highly competitive, with many companies vying for market share. Some of the major players in the market include GlaxoSmithKline, Pfizer, Merck, Novartis, and AstraZeneca. Other companies in the market include Sanofi, Takeda, and Daiichi Sankyo. Show Less Read more